Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RoslinCT is a leading global CDMO specializing in advanced cell and gene therapies. It was one of the first organizations to produce clinical-grade human pluripotent stem cells and has supported the development of the first CRISPR-edited cell therapy product for an inherited disorder. The company provides process development, analytical services, cGMP manufacturing for both autologous/allogeneic products across multiple therapeutic modalities. It operates state-of-the-art facilities in Edinburgh (UK) and Hopkinton, Massachusetts (US), serving international pharma/biotech clients from early-stage to commercial production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RoslinCT.